This site looks better in landscape mode

AKLRD develops novel solutions for inflammatory diseases with a high unmet need

AKLRD develops novel solutions for inflammatory diseases with a high unmet need

Over 50%

Over half of people diagnosed with knee osteoarthritis are under 65 years of age

NEWS

AKLRD at OARSI 2022

Read More

NEWS

Senescence Research in APPA with INIBIC

Read More

NEWS

Completion of Phase 2a Human Trial

Read More

NEWS

 

AKLRD at OARSI 2022

Read More

 

Senescence Research in APPA with INIBIC

Read More

 

Completion of Phase 2a Human Trial

Read More